Clever-Access

Last weekend, some of us participated in a charity run to support The Foch Foundation, a public utility since 1929, and its groundbreaking work. From investing in cutting-edge neuroscience research and AI-enhanced medical imaging to advancing lung transplantation with Canadian partners, The Foch Foundation is at the forefront of medical innovation. Notably, it is working on restoring standing & walking function in paraplegic patients through the PARASTIM study. For many of us, this run was a personal challenge—we pushed our limits, trained for weeks, and supported each other every step of the way to ensure we crossed the finish line together. Now, we pass the Flame to our colleagues based in other countries!" #fondationfoch #innovativeresearch #Pushyourlimits #Teamwork

Exciting News: Clever-Access and Assignity Merge! After two years of successful collaboration that has greatly benefited our clients, we are thrilled to announce that Clever-Access and Assignity have decided to take our partnership to the next level. A New Chapter Begins Today marks a significant milestone as we merge to form a single legal entity under the Clever-Access brand. This strategic move is designed to enhance clarity and strengthen our unified approach, bringing together a cohesive team of over 80 talented colleagues. What This Means for Our Clients - Streamlined Services: By combining our expertise, we will streamline our high-quality services, ensuring that our clients receive even better solutions tailored to their needs. - Enhanced Market Presence: Our merger will bolster our market presence, allowing us to serve our clients more effectively and expand our reach globally. Looking Ahead We are incredibly excited about this new chapter and the opportunities it brings. Together, we will continue to innovate and deliver exceptional value to our clients as we embark on this great adventure. Thank you for your continued support, and we look forward to what the future holds!    #CleverAccess #Assignity #Merger #HTA #HEOR #MarketAccess #ClientSuccess

Exciting News: Clever-Access and Assignity Merge! After two years of successful collaboration that has greatly benefited our clients, we are thrilled to announce that Clever-Access and Assignity have decided to take our partnership to the next level. A New Chapter Begins Today marks a significant milestone as we merge to form a single legal entity under the Clever-Access brand. This strategic move is designed to enhance clarity and strengthen our unified approach, bringing together a cohesive team of over 80 talented colleagues. What This Means for Our Clients - Streamlined Services: By combining our expertise, we will streamline our high-quality services, ensuring that our clients receive even better solutions tailored to their needs. - Enhanced Market Presence: Our merger will bolster our market presence, allowing us to serve our clients more effectively and expand our reach globally. Looking Ahead We are incredibly excited about this new chapter and the opportunities it brings. Together, we will continue to innovate and deliver exceptional value to our clients as we embark on this great adventure. Thank you for your continued support, and we look forward to what the future holds!    #CleverAccess #Assignity #Merger #HTA #HEOR #MarketAccess #ClientSuccess

We previously discussed #QALYs in #HealthEconomicEvaluations ? But to calculate #QALYs, you need #utilities 😀 ! These are subjective values, and estimate the perception of #QualityOfLife at a certain point in time. This video describes the main methods to derive such estimates. #TTO #VAS #SG, #EQ5D, etc... these are key words you may have herd before. Wanna understand them better? Of note : all the links we share contain a summary PDF you can download, summarizing the video, so don't hesitate ! https://lnkd.in/e-7jxrfa

⬟ Join us as an author for the Journal of Market Access and Health Policy (JMAHP)! ⬟ 🗎 Are you eager to share your expertise? 🗎 Do you want to foster international dialogue by presenting your research and insights in the field of market access? 🔍 MDPI Journal seeks authors like you! 🧑 In line with MAS’s vision the JMAHP conveys transparency and consolidates knowledge around the market access research area. To assist in your decision-making process, we've crafted a video outlining essential details about collaborating with our journal. Make a significant impact on the healthcare industry. Join us as an author for the Journal of Market Access and Health Policy today! 🌐 https://lnkd.in/df8th6yP #researchImpact #journals #openaccesspublishing #mdpi

🎙MODULE 4bis EMAUD! Meet the lecturers!🎙 Meet Emilie Clay, Co-Founder of Clever Access! Emilie is a biostatistician with a PhD in health economics. Her career began at Creativ-Ceutical during her end-of-studies internship, where she ascended over 12 years to the role of Vice-President of the HEOR group. In this capacity, Emilie oversaw three technical departments, including Modelling, Data Analytics, and Patient-Centered Research, showcasing her leadership prowess and expertise in health economic modeling. She spent six years as a Modeller before assuming leadership of the Modelling team for over three years. 📝 Sign up now for module 4bis : https://lnkd.in/eKFQjzkB  #mas #emaud #marketaccesscourse #elearning 

Reviewing existing economic models is crucial for new cost-effectiveness analyses. Beata Smela and her team explored different approaches to this review. You can reach out to her to check out the poster she's presenting on this topic.

Beata Smela will be presenting multiple posters at #ISPORAnnual in Atlanta, including one focusing on a comprehensive search filter for RCTs. Don't miss it!

#QALY in #HealthEconomicEvaluations, what else? 😀 A lot is going on, but QALY is the standard approach in many countries. Want to understand this better ? Of note : all the links we share contain a summary PDF you can download, summarizing the video, so don't hesitate ! https://lnkd.in/eG8jAQEg

You already know a lot about #marketaccess in #vaccines thanks to our first video. Let's see what else you can learn from the second part, focusing on vaccination calendar (1-marketing authorization, 2- recommendation for inclusion 3- final decision) ! Thanks Anna Kapusniak, our expert in #MarketAccess pathways and policies for #Vaccines. And as always, don't hesitate to come to us if you have questions 🤗 ! https://lnkd.in/eHq2xacX